Which statement describes the standard induction therapy for cryptococcal meningitis in HIV patients?

Which statement describes the standard induction therapy for cryptococcal meningitis in HIV patients?

• A. Fluconazole monotherapy
• B. Fluconazole plus flucytosine
• C. Voriconazole monotherapy
• D. Amphotericin B (liposomal) plus flucytosine

Answer: (D)

Induction therapy for cryptococcal meningitis in HIV patients aims to rapidly lower the fungal burden in the cerebrospinal fluid, because faster sterilization improves outcomes. The combination of amphotericin B (liposomal form preferred) with flucytosine achieves this best: the two drugs work together to kill the fungus more quickly than either alone, leading to faster CSF culture sterilization and better survival. The liposomal formulation reduces toxicity, which is important in patients who may have kidney issues or other health problems, making this regimen both effective and safer in the long run. After the induction phase, treatment typically transitions to consolidation with fluconazole. Fluconazole monotherapy is not potent enough to rapidly sterilize the CSF for induction. Fluconazole plus flucytosine can be used when amphotericin B is not available, but it is not considered the standard induction regimen. Voriconazole alone has not shown the same proven efficacy for induction in cryptococcal meningitis.

Induction therapy for cryptococcal meningitis in HIV patients aims to rapidly lower the fungal burden in the cerebrospinal fluid, because faster sterilization improves outcomes. The combination of amphotericin B (liposomal form preferred) with flucytosine achieves this best: the two drugs work together to kill the fungus more quickly than either alone, leading to faster CSF culture sterilization and better survival. The liposomal formulation reduces toxicity, which is important in patients who may have kidney issues or other health problems, making this regimen both effective and safer in the long run. After the induction phase, treatment typically transitions to consolidation with fluconazole.

Fluconazole monotherapy is not potent enough to rapidly sterilize the CSF for induction. Fluconazole plus flucytosine can be used when amphotericin B is not available, but it is not considered the standard induction regimen. Voriconazole alone has not shown the same proven efficacy for induction in cryptococcal meningitis.